Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer
Clinical trial NCT00305617 · COMPLETED
Trial details
- NCT number
- NCT00305617
- Sponsor
- The Cleveland Clinic
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2007-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.